Short-Chain Fatty Acid Production by Gut Microbiota Predicts Treatment Response in Multiple MyelomaAlba Rodríguez-García, María Linares, Noemí Puig et al.|Clinical Cancer Research|2023Cited by 59
Impact of COVID-19 in patients with multiple myeloma based on a global data networkJoaquín Martínez‐López, Gema Hernández, R. Alonso et al.|Blood Cancer Journal|2021Cited by 59
Microbiota-derived urolithin A in monoclonal gammopathies and multiple myeloma therapyAlba Rodríguez-García, María José Pedraja Linares, Raquel Ancos-Pintado et al.|Microbiome|2025Cited by 15
A typical acute lymphoblastic leukemia JAK2 variant, R683G, causes an aggressive form of familial thrombocytosis when germlineGonzalo Carreño‐Tarragona, Rosa Ayala, Leila N. Varghese et al.|Leukemia|2021Cited by 12
Genetic Alterations in Members of the Proteasome 26S Subunit, AAA-ATPase (PSMC) Gene Family in the Light of Proteasome Inhibitor Resistance in Multiple MyelomaLarissa Haertle, Joaquín Martínez‐López, Natalia Buenache et al.|Cancers|2023Cited by 12